1043
Trends in the Frequency of HIV Testing and CD4 Count at Time of Diagnosis among Persons Tested through a Public Health Program: Seattle, Washington, 1995 to 2008
Matthew Golden*1,2, J Stekler1,2, and R Wood1,2
1Publ Hlth-Seattle & King County, WA, US and 2Ctr for AIDS and STD, Univ of Washington, Seattle, US
Background: Diagnosing persons with HIV soon after
infection could decrease HIV transmission and HIV-associated morbidity.
Methods: We analyzed data collected as part of a
public health HIV testing program and a related effort that provides CD4
testing to newly diagnosed persons in Seattle, Washington. We assessed trends
in HIV testing history and CD4 count at time of HIV diagnosis using c2 tests and robust linear
regression.
Results: From January 1995 to July 2008, 696 (0.8%)
persons were newly diagnosed with HIV during 85,762 testing encounters. Records
included self-reported HIV testing history for 591 (85%) persons, 488 (83%) of
whom were men who have sex with men (MSM). The proportion of newly diagnosed
MSM who reported never previously HIV testing decreased from 25% in 1995 to 1996
to 5% in 2007 to 2008 (p <0.0001), but remained stable in non-MSM
(mean for 2-year periods 40%, range 24 to 60%) (p = 0.8). The median
time between last HIV– test and first HIV+ test
(inter-test interval) among MSM decreased from 692 to 248 days (p <0.0001).
Among non-MSM the median inter-test interval was 805 days (range for 2-year
periods 533 to 1702 days), with no temporal trend (p = 0.5). During this
same period, 619 persons had CD4 counts measured near the time of HIV
diagnosis, 495 (80%) of whom were MSM. The median CD4 count among MSM increased
from 390 in 1995 to 1996 to 487 in 2007 to 2008 (p = 0.002). Among
non-MSM, the median CD4 count increased from 337 in 1995 to 2000 to 407 in 2001
to 2008 (p = 0.04). Patient reported data on HIV testing history were
available for 406 (66%) persons, of whom 347 reported a prior negative test.
Shorter inter-test interval was associated with a higher CD4 count, but
explained little of the observed CD4 count variance (p = 0.03, R2
= 0.014). Among 145 persons HIV tested in the preceding year, 6 (5%) had CD4
counts <200, and 27 (19%) had CD4 counts <350; 36 (45%) of the 75 persons
with CD4 counts <200 reported that they had HIV tested in the preceding 2
years. Overall, 66% of all persons diagnosed with HIV had CD4 counts >350.
Conclusions: These data suggest that persons with
HIV, particularly MSM, are being diagnosed earlier in their infection. Many
persons with low CD4 counts have HIV tested fairly recently, and may be
misclassified as late diagnoses. A growing proportion of persons with newly
diagnosed HIV are not candidates for immediate antiretroviral therapy using
current guidelines. The generlizability of these findings is uncertain.
|